pharmacopeia

Gluconate

US-FDASourced from openFDA
GET
/api/v1/drug/gluconate

Indications

Sourced from openFDA
  • Use healthcare personnel handwash: helps reduce bacteria that potentially can cause disease

Dosage & administration

Sourced from openFDA

Directions use with care in premature infants and infants under 2 months of age. These products may cause irritation or chemical burns. Healthcare personnel handwash: wet hands with water dispense about 5 mL of product into cupped hands and wash in a vigorous manner for 30 seconds rinse and dry thoroughly

Warnings & precautions

Sourced from openFDA

For external use only Allergy alert: This product may cause a severe allergic reaction. Symptoms may include: wheezing/difficulty breathing shock facial swelling hives rash If an allergic reaction occurs, stop use and seek medical help right away. Do not use if you are allergic to chlorhexidine gluconate or any other ingredient in this product When using this product keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye or may cause deafness when instilled in the middle ear through perforated eardrums. if solution should contact these areas, rinse out promptly and thoroughly with water do not use routinely if you have wounds which involve more than the superficial layers of the skin Stop use and ask a doctor if irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Approval history

Sourced from openFDA
  • Aug 13, 1975NDANDA017586Otsuka Icu Medcl
  • Aug 13, 1975NDANDA017609Otsuka Icu Medcl
  • Sep 17, 1976NDANDA017768Molnlycke Hlth
  • Feb 2, 1979NDANDA017378Baxter Hlthcare
  • Jun 8, 1984NDANDA019024B Braun
  • Dec 24, 1984NDANDA019125Xttrium
  • Dec 24, 1984NDANDA019127Xttrium
  • Dec 17, 1985NDANDA019422Xttrium

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
48,026 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Fatigue6,22213%
  2. 2Pain5,40911%
  3. 3Drug Ineffective4,97410%
  4. 4Off Label Use4,7789.9%
  5. 5Nausea4,4199.2%
  6. 6Diarrhoea4,3629.1%
  7. 7Dyspnoea4,1808.7%
  8. 8Rash3,9728.3%
  9. 9Headache3,9668.3%
  10. 10Arthralgia3,8938.1%
  11. 11Vomiting3,6337.6%
  12. 12Alopecia3,2736.8%
  13. 13Pruritus3,1906.6%
  14. 14Pyrexia3,1326.5%
  15. 15Dizziness3,0826.4%

Literature

View JSON

Recent PubMed references pinned to Gluconate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 615 ClinicalTrials.gov registrations naming Gluconate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

What is Gluconate used for?
According to FDA labeling, Gluconate carries indications including: Use healthcare personnel handwash: helps reduce bacteria that potentially can cause disease. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for gluconate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients